Analysts Are Bullish on These Healthcare Stocks: Crinetics Pharmaceuticals (CRNX), Lipella Pharmaceuticals, Inc. (LIPO)
Lipella Pharmaceuticals (LIPO.US) was first covered by Maxim Group and given a buy rating, with a target price of $2.00.
Lipella Pharmaceuticals Analyst Ratings
No Data